245 related articles for article (PubMed ID: 2358779)
1. The generation of natural killer (NK) cells from NK precursor cells in rat long-term bone marrow cultures.
van den Brink MR; Boggs SS; Herberman RB; Hiserodt JC
J Exp Med; 1990 Jul; 172(1):303-13. PubMed ID: 2358779
[TBL] [Abstract][Full Text] [Related]
2. Generation of natural killer cells from Thy 1.1+ bone marrow precursor cells in the rat.
van den Brink MR; Herberman RB; Hiserodt JC
Blood; 1991 Nov; 78(9):2392-5. PubMed ID: 1681963
[TBL] [Abstract][Full Text] [Related]
3. Long-term cultures of mouse bone marrow cells: a model for studying the generation of natural killer cells.
Ayroldi E; Cannarile L; D'Adamio F; Delfino D; Migliorati G; Riccardi C
Nat Immun; 1992; 11(6):317-27. PubMed ID: 1477494
[TBL] [Abstract][Full Text] [Related]
4. Generation of natural killer cells from long-term cultures of mouse bone marrow.
Vecchini F; Delfino D; Patrene KD; DeLeo A; Lu L; Herberman RB; Boggs SS
Nat Immun; 1993; 12(1):1-16. PubMed ID: 8431659
[TBL] [Abstract][Full Text] [Related]
5. Lymphokine-activated killer cells in rats: generation of natural killer cells and lymphokine-activated killer cells from bone marrow progenitor cells.
Sarneva M; Vujanovic NL; Van den Brink MR; Herberman RB; Hiserodt JC
Cell Immunol; 1989 Feb; 118(2):448-57. PubMed ID: 2910504
[TBL] [Abstract][Full Text] [Related]
6. Natural killer cell precursors in the CD44neg/dim T-cell receptor population of mouse bone marrow.
Delfino DV; Patrene KD; Lu J; Deleo A; Deleo R; Herberman RB; Boggs SS
Blood; 1996 Mar; 87(6):2394-400. PubMed ID: 8630403
[TBL] [Abstract][Full Text] [Related]
7. Lymphokine-activated killer cells in rats. IV. Developmental relationships among large agranular lymphocytes, large granular lymphocytes, and lymphokine-activated killer cells.
Maghazachi AA; Vujanovic NL; Herberman RB; Hiserodt JC
J Immunol; 1988 Apr; 140(8):2846-52. PubMed ID: 3258622
[TBL] [Abstract][Full Text] [Related]
8. Natural killer (NK) cell activity in human long-term bone marrow cultures (LTBMC): effects of interleukin-2 (IL-2) and granulocyte-macrophage colony-stimulating factor (GM-CSF) on the progenitor cells.
Sitnicka E; Hansson M
Immunology; 1992 Jun; 76(2):292-8. PubMed ID: 1634251
[TBL] [Abstract][Full Text] [Related]
9. Lymphokine-activated killer cells in rats: analysis of progenitor and effector cell phenotype and relationship to natural killer cells.
Vujanovic NL; Herberman RB; Olszowy MW; Cramer DV; Salup RR; Reynolds CW; Hiserodt JC
Cancer Res; 1988 Feb; 48(4):884-90. PubMed ID: 3257412
[TBL] [Abstract][Full Text] [Related]
10. Adherent lymphokine-activated killer cells suppress autologous human normal bone marrow progenitors.
Miller JS; Verfaillie C; McGlave P
Blood; 1991 Jun; 77(11):2389-95. PubMed ID: 1903991
[TBL] [Abstract][Full Text] [Related]
11. Lymphokine-activated killer cells in rats. III. A simple method for the purification of large granular lymphocytes and their rapid expansion and conversion into lymphokine-activated killer cells.
Vujanovic NL; Herberman RB; Maghazachi AA; Hiserodt JC
J Exp Med; 1988 Jan; 167(1):15-29. PubMed ID: 3257251
[TBL] [Abstract][Full Text] [Related]
12. Genesis of human oncolytic natural killer cells from primitive CD34+CD33- bone marrow progenitors.
Lotzová E; Savary CA; Champlin RE
J Immunol; 1993 Jun; 150(12):5263-9. PubMed ID: 7685792
[TBL] [Abstract][Full Text] [Related]
13. Autologous activated natural killer cells suppress primitive chronic myelogenous leukemia progenitors in long-term culture.
Cervantes F; Pierson BA; McGlave PB; Verfaillie CM; Miller JS
Blood; 1996 Mar; 87(6):2476-85. PubMed ID: 8630414
[TBL] [Abstract][Full Text] [Related]
14. Natural killer and lymphokine-activated killer cell activities from human marrow precursors. II. The effects of IL-3 and IL-4.
Keever CA; Pekle K; Gazzola MV; Collins NH; Bourhis JH; Gillio A
J Immunol; 1989 Nov; 143(10):3241-9. PubMed ID: 2809200
[TBL] [Abstract][Full Text] [Related]
15. Role of interleukin 2 (IL 2) and hemopoietin-1 (H-1) in the generation of mouse natural killer (NK) cells from primitive bone marrow precursors.
Migliorati G; Cannarile L; Herberman RB; Bartocci A; Stanley ER; Riccardi C
J Immunol; 1987 Jun; 138(11):3618-25. PubMed ID: 2884255
[TBL] [Abstract][Full Text] [Related]
16. Production and differentiation of NK lineage cells in long-term bone marrow cultures in the absence of exogenous growth factors.
Pollack SB; Tsuji J; Rosse C
Cell Immunol; 1992 Feb; 139(2):352-62. PubMed ID: 1733507
[TBL] [Abstract][Full Text] [Related]
17. Origin and differentiation of natural killer cells. I. Characteristics of a transplantable NK cell precursor.
Hackett J; Bennett M; Kumar V
J Immunol; 1985 Jun; 134(6):3731-8. PubMed ID: 3989295
[TBL] [Abstract][Full Text] [Related]
18. Effects of rIL-7 on murine bone marrow NK precursor cells.
Pollack SB; Tsuji J
Cell Immunol; 1993 Oct; 151(1):1-11. PubMed ID: 8402921
[TBL] [Abstract][Full Text] [Related]
19. Cooperative effects of colony-stimulating factor 1 and recombinant interleukin 2 on proliferation and induction of cytotoxicity of macrophage precursors generated from mouse bone marrow cell cultures.
Li H; Schwinzer R; Baccarini M; Lohmann-Matthes ML
J Exp Med; 1989 Mar; 169(3):973-86. PubMed ID: 2784482
[TBL] [Abstract][Full Text] [Related]
20. Combined therapy of mice bearing a lymphokine-activated killer-resistant tumor with recombinant interleukin 2 and an antitumor monoclonal antibody capable of inducing antibody-dependent cellular cytotoxicity.
Kawase I; Komuta K; Hara H; Inoue T; Hosoe S; Ikeda T; Shirasaka T; Yokota S; Tanio Y; Masuno T
Cancer Res; 1988 Mar; 48(5):1173-9. PubMed ID: 3257715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
